TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent November 18, 2011
TCL Archive NCI Cancer Bulletin publicized board’s resignation over liability concerns. April 16, 2004
TCL Archive An “insurgency” targets randomized trials, demands access to investigational drugs. August 5, 2005